Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Повний опис

Бібліографічні деталі
Автори:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Формат:	Journal article
Мова:	English
Опубліковано:	Wiley Open Access 2024

Схожі ресурси

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
за авторством: Helia Givian, та інші
Опубліковано: (2024-12-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
за авторством: Jorge Garcia Condado, та інші
Опубліковано: (2023-10-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
за авторством: Oulhaj, A, та інші
Опубліковано: (2016)

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease
за авторством: Michael J. Pearson, та інші
Опубліковано: (2024-07-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
за авторством: Ali Azargoonjahromi, та інші
Опубліковано: (2024-12-01)

Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up
за авторством: Asma Hallab, та інші
Опубліковано: (2024-09-01)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
за авторством: de Jager, C, та інші
Опубліковано: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
за авторством: De Jager, C, та інші
Опубліковано: (2012)

Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment
за авторством: Chen Xue, та інші
Опубліковано: (2024-08-01)

Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment
за авторством: Chao Wang, та інші
Опубліковано: (2024-06-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
за авторством: Xiaoming Zheng, та інші
Опубліковано: (2024-10-01)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
за авторством: Lanlan Li, та інші
Опубліковано: (2021-01-01)

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using an Explainable AI Approach
за авторством: Gerasimos Grammenos, та інші
Опубліковано: (2024-04-01)

Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods
за авторством: Baiwen Zhang, та інші
Опубліковано: (2024-06-01)

Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
за авторством: Boyue Song, та інші
Опубліковано: (2024-01-01)

Imputation-Based Variable Selection Method for Block-Wise Missing Data When Integrating Multiple Longitudinal Studies
за авторством: Zhongzhe Ouyang, та інші
Опубліковано: (2024-03-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
за авторством: Guanan Zhao, та інші
Опубліковано: (2024-01-01)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
за авторством: Jones, S, та інші
Опубліковано: (2017)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
за авторством: Stockman, CA, та інші
Опубліковано: (2024)

Longitudinal accelerated brain age in mild cognitive impairment and Alzheimer’s disease
за авторством: Maria Ly, та інші
Опубліковано: (2024-10-01)

Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer’s Disease
за авторством: Xiao-jun Jing, та інші
Опубліковано: (2024-09-01)

Sex Differences in Conversion Risk from Mild Cognitive Impairment to Alzheimer’s Disease: An Explainable Machine Learning Study with Random Survival Forests and SHAP
за авторством: Alessia Sarica, та інші
Опубліковано: (2024-02-01)

Random forest prediction of Alzheimer's disease using pairwise selection from time series data
за авторством: Moore, P, та інші
Опубліковано: (2019)

Classification of Alzheimer’s and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
за авторством: Seyed Hossein Nozadi, та інші
Опубліковано: (2018-01-01)

Brain age gap estimation using attention-based ResNet method for Alzheimer’s disease detection
за авторством: Atefe Aghaei, та інші
Опубліковано: (2024-06-01)

Homocysteine, B vitamins, and cognitive impairment
за авторством: Smith, A, та інші
Опубліковано: (2016)

Homocysteine, B vitamins, and cardiovascular disease
за авторством: Refsum, H, та інші
Опубліковано: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
за авторством: Refsum, H, та інші
Опубліковано: (2006)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
за авторством: Smith, A, та інші
Опубліковано: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
за авторством: Smith, A, та інші
Опубліковано: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
за авторством: Smith, A, та інші
Опубліковано: (2010)

Learning semi-supervised enrichment of longitudinal imaging-genetic data for improved prediction of cognitive decline
за авторством: Hoon Seo, та інші
Опубліковано: (2024-05-01)

Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer’s disease
за авторством: Yaqiong Xiao, та інші
Опубліковано: (2024-05-01)

Multiple phenotype association tests based on sliced inverse regression
за авторством: Wenyuan Sun, та інші
Опубліковано: (2024-04-01)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
за авторством: Nurk, E, та інші
Опубліковано: (2005)

Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression
за авторством: Palma, M, та інші
Опубліковано: (2020)

Impact of APOE-ε alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
за авторством: Colleen Lacey, та інші
Опубліковано: (2024-01-01)

The Association among Hypothalamic Subnits, Gonadotropic and Sex Hormone Plasmas Levels in Alzheimer’s Disease
за авторством: Edward Ofori, та інші
Опубліковано: (2024-03-01)

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer’s Disease beyond the Cortex
за авторством: Zhengshi Yang, та інші
Опубліковано: (2024-01-01)

Polygenic Score for Conscientiousness Is a Protective Factor for Reversion from Mild Cognitive Impairment to Normal Cognition
за авторством: Xuan Yang, та інші
Опубліковано: (2024-08-01)